Revolution Medicines Inc
NASDAQ:RVMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
Telstra Corporation Ltd
ASX:TLS
|
AU |
|
IDEC Corp
TSE:6652
|
JP |
|
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
JP |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
Agnico Eagle Mines Ltd
TSX:AEM
|
CA |
|
Swire Pacific Ltd
HKEX:19
|
HK |
|
DCI Indonesia Tbk PT
IDX:DCII
|
ID |
|
J
|
JCU Corp
TSE:4975
|
JP |
|
EPR Properties
NYSE:EPR
|
US |
|
A
|
ACG Acquisition Company Ltd
LSE:ACG
|
VG |
|
A
|
African Rainbow Capital Investments Ltd
JSE:AIL
|
MU |
|
CCR SA
BOVESPA:CCRO3
|
BR |
|
Carmax Inc
NYSE:KMX
|
US |
|
Daqin Railway Co Ltd
SSE:601006
|
CN |
|
Safran SA
PAR:SAF
|
FR |
|
Mitsubishi Estate Co Ltd
TSE:8802
|
JP |
|
N
|
NoHo Partners Oyj
OMXH:NOHO
|
FI |
|
Carpenter Technology Corp
NYSE:CRS
|
US |
|
Equifax Inc
NYSE:EFX
|
US |
|
E
|
Evli Oyj
OMXH:EVLI
|
FI |
|
Deutsche Telekom AG
XETRA:DTE
|
DE |
|
Johnson Controls International PLC
NYSE:JCI
|
IE |
|
Northeast Community Bancorp Inc
NASDAQ:NECB
|
US |
Bankruptcy Probability
Revolution Medicines Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Revolution Medicines Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
30.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Revolution Medicines Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Revolution Medicines Inc has total debt of 268.4m USD. This includes both short-term (0 USD) and long-term (268.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
